Cristiano Dani , Sara Giachetti , Matteo Mura , Sara Tedesco , Eleonora Rossi , Emanuele Cassioli , Livio Tarchi , Nadia Micali , Valdo Ricca , Giovanni Castellini
{"title":"研究胃饥饿素及其在饮食失调中的亚型:一项网络荟萃分析","authors":"Cristiano Dani , Sara Giachetti , Matteo Mura , Sara Tedesco , Eleonora Rossi , Emanuele Cassioli , Livio Tarchi , Nadia Micali , Valdo Ricca , Giovanni Castellini","doi":"10.1016/j.pnpbp.2025.111489","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Eating disorders (EDs) are serious psychiatric conditions disorders characterized by impairments in appetite regulation and energy balance. Among the biological factors implicated in their pathophysiology, the orexigenic hormone ghrelin and its isoforms (acyl-ghrelin [AG] and desacyl-ghrelin [DAG]) have been shown to play a key role in appetite regulation and may contribute to the maintenance of disordered eating behaviors.</div></div><div><h3>Methods</h3><div>A systematic review of existing literature and meta-analysis were conducted, including 80 studies examining fasting blood levels of ghrelin, AG, and DAG across various ED diagnostic categories and healthy controls (HC), including also individuals with recovered AN (AN-rec). A network meta-analysis (NMA) approach through a multilevel linear mixed-effects meta-regression model was employed to estimate hormone levels, while accounting for covariates such as body mass index (BMI), sex, blood composition and assay type.</div></div><div><h3>Results</h3><div>Ghrelin levels were significantly elevated in individuals with anorexia nervosa (AN) and bulimia nervosa (BN) when compared to HC, while binge eating disorder (BED) was associated with lower ghrelin levels than individuals with BN and HC. AG and DAG levels were significantly elevated in individuals with AN compared to HC, and confirmed higher in AN-rec if compared to HC. No significant differences in ghrelin, AG and DAG levels were observed for avoidant/restrictive food intake disorder (ARFID).</div></div><div><h3>Conclusions</h3><div>This meta-analysis highlighted significant differences in the levels of ghrelin and its isoforms across various ED subgroups and HC, emphasizing their potential roles in the pathophysiology of these disorders, in a perspective of potential targeted therapeutic implications.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"142 ","pages":"Article 111489"},"PeriodicalIF":3.9000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Investigating ghrelin and its isoforms in eating disorders: a network meta-analysis\",\"authors\":\"Cristiano Dani , Sara Giachetti , Matteo Mura , Sara Tedesco , Eleonora Rossi , Emanuele Cassioli , Livio Tarchi , Nadia Micali , Valdo Ricca , Giovanni Castellini\",\"doi\":\"10.1016/j.pnpbp.2025.111489\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Eating disorders (EDs) are serious psychiatric conditions disorders characterized by impairments in appetite regulation and energy balance. Among the biological factors implicated in their pathophysiology, the orexigenic hormone ghrelin and its isoforms (acyl-ghrelin [AG] and desacyl-ghrelin [DAG]) have been shown to play a key role in appetite regulation and may contribute to the maintenance of disordered eating behaviors.</div></div><div><h3>Methods</h3><div>A systematic review of existing literature and meta-analysis were conducted, including 80 studies examining fasting blood levels of ghrelin, AG, and DAG across various ED diagnostic categories and healthy controls (HC), including also individuals with recovered AN (AN-rec). A network meta-analysis (NMA) approach through a multilevel linear mixed-effects meta-regression model was employed to estimate hormone levels, while accounting for covariates such as body mass index (BMI), sex, blood composition and assay type.</div></div><div><h3>Results</h3><div>Ghrelin levels were significantly elevated in individuals with anorexia nervosa (AN) and bulimia nervosa (BN) when compared to HC, while binge eating disorder (BED) was associated with lower ghrelin levels than individuals with BN and HC. AG and DAG levels were significantly elevated in individuals with AN compared to HC, and confirmed higher in AN-rec if compared to HC. No significant differences in ghrelin, AG and DAG levels were observed for avoidant/restrictive food intake disorder (ARFID).</div></div><div><h3>Conclusions</h3><div>This meta-analysis highlighted significant differences in the levels of ghrelin and its isoforms across various ED subgroups and HC, emphasizing their potential roles in the pathophysiology of these disorders, in a perspective of potential targeted therapeutic implications.</div></div>\",\"PeriodicalId\":54549,\"journal\":{\"name\":\"Progress in Neuro-Psychopharmacology & Biological Psychiatry\",\"volume\":\"142 \",\"pages\":\"Article 111489\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in Neuro-Psychopharmacology & Biological Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S027858462500243X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S027858462500243X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Investigating ghrelin and its isoforms in eating disorders: a network meta-analysis
Background
Eating disorders (EDs) are serious psychiatric conditions disorders characterized by impairments in appetite regulation and energy balance. Among the biological factors implicated in their pathophysiology, the orexigenic hormone ghrelin and its isoforms (acyl-ghrelin [AG] and desacyl-ghrelin [DAG]) have been shown to play a key role in appetite regulation and may contribute to the maintenance of disordered eating behaviors.
Methods
A systematic review of existing literature and meta-analysis were conducted, including 80 studies examining fasting blood levels of ghrelin, AG, and DAG across various ED diagnostic categories and healthy controls (HC), including also individuals with recovered AN (AN-rec). A network meta-analysis (NMA) approach through a multilevel linear mixed-effects meta-regression model was employed to estimate hormone levels, while accounting for covariates such as body mass index (BMI), sex, blood composition and assay type.
Results
Ghrelin levels were significantly elevated in individuals with anorexia nervosa (AN) and bulimia nervosa (BN) when compared to HC, while binge eating disorder (BED) was associated with lower ghrelin levels than individuals with BN and HC. AG and DAG levels were significantly elevated in individuals with AN compared to HC, and confirmed higher in AN-rec if compared to HC. No significant differences in ghrelin, AG and DAG levels were observed for avoidant/restrictive food intake disorder (ARFID).
Conclusions
This meta-analysis highlighted significant differences in the levels of ghrelin and its isoforms across various ED subgroups and HC, emphasizing their potential roles in the pathophysiology of these disorders, in a perspective of potential targeted therapeutic implications.
期刊介绍:
Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject.
Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.